Hideki Amano
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Oncology top 10%
- Lymphatic System and Diseases
Papers in
-
- Angiogenesis and VEGF in Cancer 20
- Pharmacology 20
- Inflammatory mediators and NSAID effects 18
- Co-authors
- Masataka Majima (53 shared papers)Yoshiya Ito (45 shared papers)Izumi Hayashi (11 shared papers)Kanako Hosono (32 shared papers)Hidero Kitasato (15 shared papers)Shuh Narumiya (14 shared papers)Fumihiro Ogawa (16 shared papers)Hirokuni Yoshimura (5 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (13 papers)Laboratory Investigation (3 papers)Cancer Science (3 papers)Journal of Surgical Research (2 papers)Cardiovascular Research (2 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Hideki Amano
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 484
- Oncology 451
- Biochemistry 116
- Rehabilitation 106
- Genetics 157
Countries citing papers authored by Hideki Amano
This map shows the geographic impact of Hideki Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Amano more than expected).
Fields of papers citing papers by Hideki Amano
This network shows the impact of papers produced by Hideki Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Amano. The network helps show where Hideki Amano may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Amano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 283 | |
| 2 | 2014 | 113 | |
| 3 | 2008 | 106 | |
| 4 | 2003 | 78 | |
| 5 | 2014 | 78 | |
| 6 | 2003 | 62 | |
| 7 | 2009 | 54 | |
| 8 | 2019 | 51 | |
| 9 | 2006 | 47 | |
| 10 | 2002 | 41 | |
| 11 | 2012 | 40 | |
| 12 | 2011 | 36 | |
| 13 | 2009 | 34 | |
| 14 | 2015 | 33 | |
| 15 | 2012 | 30 | |
| 16 | 2013 | 30 | |
| 17 | 2013 | 29 | |
| 18 | 2018 | 29 | |
| 19 | 2017 | 28 | |
| 20 | 2013 | 28 |
About Hideki Amano
Hideki Amano is a scholar working on Molecular Biology, Pharmacology, Oncology, Surgery and Immunology, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (20 papers), Inflammatory mediators and NSAID effects (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Lymphatic System and Diseases (7 papers), Cancer, Stress, Anesthesia, and Immune Response (6 papers), Estrogen and related hormone effects (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). The work is most often cited by research in Pharmacology (484 citations), Oncology (451 citations), Biochemistry (116 citations), Rehabilitation (106 citations) and Genetics (157 citations). Hideki Amano has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Masataka Majima, Yoshiya Ito, Izumi Hayashi, Kanako Hosono, Hidero Kitasato, Shuh Narumiya, Fumihiro Ogawa, Hirokuni Yoshimura, Yukitoshi Satoh and Koji Eshima. Their work appears in journals such as Biomedicine & Pharmacotherapy, Laboratory Investigation, Cancer Science, Journal of Surgical Research and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.